NYLIM
EBS icon

New York Life Investment Management’s Emergent Biosolutions EBS Stock Holding History

New York Life Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,982
Closed -$79.2K – 1382
2023
Q4 		$79.2K Sell
32,982
-1,385
-4% -$3.25K ﹤0.01% 1311
2023
Q3 		$117K Sell
34,367
-5,414
-14% -$30K ﹤0.01% 1289
2023
Q2 		$292K Sell
39,781
-10,745
-21% -$99.6K ﹤0.01% 1246
2023
Q1 		$523K Buy
+50,526
New +$611K 0.01% 651

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

New York Life Investment Management's EBS Position: Q1 2024 in Review

New York Life Investment Management sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 32,982 shares — an estimated $79.2K sold.

New York Life Investment Management first reported a position in EBS in Q1 2023 and held it in 4 quarters. The position peaked at $523K in Q1 2023. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • New York Life Investment Management reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 32,982 Emergent Biosolutions shares in Q1 2024, an estimated $79.2K.
  • New York Life Investment Management first reported a position in Emergent Biosolutions in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Emergent Biosolutions position peaked at $523K in Q1 2023.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.